Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
NCT05015426
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
Gamma Delta T-Cell Infusion
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
[object Object]